Damian, S., Lorusso, D., Simonelli, M., Homicsko, K., Colombo, I., Cassier, P. A., Velden, M. V. D., Richards, E. C., Kinder, M., Liu, Q., Wang, E. W., Kitano, S. (2025). Safety and preliminary efficacy from a phase 1 study of INCB123667, a selective CDK2 inhibitor, in patients with advanced platinum-resistant and refractory ovarian cancer (OC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5514